Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination of intra-articular hyaluronan and corticosteroids for knee osteoarthritis
2005-004076-21Phase 4Active
- Sponsor
- ESTHER URIARTE ITZAZELAIA
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium hyaluronate and triamcinolone acetonide in knee osteoarthritis (OA), sponsored by ESTHER URIARTE ITZAZELAIA. Primary endpoints: Pain reduction at 6 weeks and Pain reduction at 3 months. Started Oct 2005; status: active.
02
Drugs
sodium hyaluronatetriamcinolone acetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-004076-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004076-21.